Regular use of aspirin and other non-steroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: a cohort study
Rebecca D Kehm, John L Hopper, Esther M John, Kelly-Anne Phillips, Robert J MacInnis, Gillian S Dite, Roger L Milne, Yuyan Liao, Nur Zeinomar, Julia A Knight, Melissa C Southey, Linda Vahdat, Naomi Kornhauser, Tessa Cigler, Wendy K Chung, Graham G Giles, Sue-Anne McLachlan, Michael L Friedlander, Prue C Weideman, Gord Glendon Show all
Breast Cancer Research | BMC | Published : 2019
Awarded by USA National Cancer Institute
Awarded by Cancer Australia
Awarded by Australian National Breast Cancer Foundation
Awarded by National Health and Medical Research Council
Awarded by National Institute of Health U.S.A.
Awarded by National Institutes of Health, National Cancer Institute, Cancer Epidemiology Training Grant
The six sites of the Breast Cancer Family Registry were supported by grant UM1 CA164920 from the USA National Cancer Institute. This work was also supported by grants to kConFab and the kConFab Follow-Up Study from Cancer Australia [grant numbers 809195, 1100868], the Australian National Breast Cancer Foundation [grant number IF 17 kConFab], the National Health and Medical Research Council [grant numbers 454508, 288704, 145684], the National Institute of Health U.S.A. [grant number 1RO1CA159868], the Queensland Cancer Fund, the Cancer Councils of New South Wales, Victoria, Tasmania, and South Australia, and the Cancer Foundation of Western Australia [grant numbers not applicable]. RDK is supported by the National Institutes of Health, National Cancer Institute, Cancer Epidemiology Training Grant [grant number T32-CA009529]. KAP is an Australian National Breast Cancer Foundation Practitioner Fellow.